(SQNM:Consolidated Issue Listed on NASDAQ Global Select )
Earnings & Estimates Summary - SEQUENOM INC (SQNM)
2013 revenues at Sequenom Inc. totaled $162.4M USD, while annual losses equaled $0.88 per share.
Quarterly Earnings & Estimates - SEQUENOM INC (SQNM)
Sequenom Inc.'s Quarterly Earnings
Sequenom Inc. reported 2nd quarter 2014 losses of $0.06 per share on 07/31/2014.
Annual Earnings & Estimates - SEQUENOM INC (SQNM)
Sequenom Inc.'s Annual Earnings
Sequenom Inc. reported annual 2013 losses of $0.88 per share on 03/1/2014.
Quarterly Revenues - SEQUENOM INC (SQNM)
Sequenom Inc.'s Quarterly Revenues
Sequenom Inc. had 2nd quarter 2014 revenues of $39.8M USD. This missed the $41.4M USD consensus estimate of the 7 analysts following the company. This was 14.1% above the prior year's 2nd quarter results.
Annual Revenues - SEQUENOM INC (SQNM)
Sequenom Inc.'s Annual Revenues
Sequenom Inc. had revenues for the full year 2013 of $162.4M USD. This was 82.5% above the prior year's results.
|Biotage AB||kr20.90 SEK||-0.60|
|Enzo Biochem Inc||$4.52 USD||-0.10|
|NanoString Technologies Inc||$14.98 USD||+0.41|
|Natera Inc||$8.73 USD||-0.16|
|Transgenomic Inc||$1.36 USD||+0.271|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.